RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Chembio Diagnostics Stock

Chembio Diagnostics Revenue 2024

Chembio Diagnostics Revenue

36.92 M USD

Ticker

CEMI

ISIN

US1635722093

WKN

A1JY4D

In 2024, Chembio Diagnostics's sales reached 36.92 M USD, a -4.98% difference from the 38.86 M USD sales recorded in the previous year.

The Chembio Diagnostics Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2025e35.7830,58
2024e36.9229,64
2023e38.8628,16
202249.5222,10
202147.8227,86
202032.4726,49
201934.4635,03
201834.5834,64
201724.0246,17
201617.8747,29
201524.2643,24
201427.6539,10
201329.5541,62
201225.6142,13
201119.3948,43
201016.748,50
200913.8342,37
200811.0534,84
20079.2330,34
20066.524,77
20053.9433,76
20043.3121,15
2003--

Chembio Diagnostics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Chembio Diagnostics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Chembio Diagnostics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Chembio Diagnostics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Chembio Diagnostics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Chembio Diagnostics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Chembio Diagnostics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Chembio Diagnostics’s growth potential.

Chembio Diagnostics Revenue, EBIT and net profit per share

DateChembio Diagnostics RevenueChembio Diagnostics EBITChembio Diagnostics Net Income
2025e35.78 M undefined-19.9 M undefined-34.8 M undefined
2024e36.92 M undefined-26.38 M undefined-40.29 M undefined
2023e38.86 M undefined-35.67 M undefined-47.57 M undefined
202249.52 M undefined-20.4 M undefined-23.29 M undefined
202147.82 M undefined-24.01 M undefined-33.9 M undefined
202032.47 M undefined-21.95 M undefined-25.52 M undefined
201934.46 M undefined-12.61 M undefined-13.68 M undefined
201834.58 M undefined-7.64 M undefined-7.87 M undefined
201724.02 M undefined-6.45 M undefined-6.37 M undefined
201617.87 M undefined-7.57 M undefined-13.35 M undefined
201524.26 M undefined-3.55 M undefined-2.4 M undefined
201427.65 M undefined-1.55 M undefined-1.14 M undefined
201329.55 M undefined1 M undefined530,000 undefined
201225.61 M undefined1.45 M undefined940,000 undefined
201119.39 M undefined1.09 M undefined6.21 M undefined
201016.7 M undefined2.57 M undefined2.51 M undefined
200913.83 M undefined320,000 undefined310,000 undefined
200811.05 M undefined-2.07 M undefined-1.95 M undefined
20079.23 M undefined-2.88 M undefined-8.27 M undefined
20066.5 M undefined-4.58 M undefined-8.21 M undefined
20053.94 M undefined-3.3 M undefined-6.77 M undefined
20043.31 M undefined-3.11 M undefined-5.04 M undefined
20030 undefined-10,000 undefined0 undefined

Chembio Diagnostics stock margins

The Chembio Diagnostics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Chembio Diagnostics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Chembio Diagnostics.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Chembio Diagnostics's sales revenue. A higher gross margin percentage indicates that the Chembio Diagnostics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Chembio Diagnostics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Chembio Diagnostics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Chembio Diagnostics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Chembio Diagnostics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Chembio Diagnostics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Chembio Diagnostics Margin History

Chembio Diagnostics Gross marginChembio Diagnostics Profit marginChembio Diagnostics EBIT marginChembio Diagnostics Profit margin
2025e22.1 %-55.62 %-97.26 %
2024e22.1 %-71.46 %-109.12 %
2023e22.1 %-91.8 %-122.44 %
202222.1 %-41.2 %-47.03 %
202127.86 %-50.2 %-70.9 %
202026.49 %-67.6 %-78.6 %
201935.03 %-36.59 %-39.7 %
201834.64 %-22.09 %-22.76 %
201746.17 %-26.85 %-26.52 %
201647.29 %-42.36 %-74.71 %
201543.24 %-14.63 %-9.89 %
201439.1 %-5.61 %-4.12 %
201341.62 %3.38 %1.79 %
201242.13 %5.66 %3.67 %
201148.43 %5.62 %32.03 %
201048.5 %15.39 %15.03 %
200942.37 %2.31 %2.24 %
200834.84 %-18.73 %-17.65 %
200730.34 %-31.2 %-89.6 %
200624.77 %-70.46 %-126.31 %
200533.76 %-83.76 %-171.83 %
200421.15 %-93.96 %-152.27 %
200322.1 %0 %0 %

Chembio Diagnostics Aktienanalyse

What does Chembio Diagnostics do?

Chembio Diagnostics Inc is a biomedical company specializing in the development and commercialization of diagnostic test kits. The company was founded in 1985 and is headquartered in Medford, New York. Chembio Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Chembio Diagnostics's Sales Figures

The sales figures of Chembio Diagnostics originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Chembio Diagnostics’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Chembio Diagnostics's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Chembio Diagnostics’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Chembio Diagnostics stock

How much revenue did Chembio Diagnostics generate this year?

Chembio Diagnostics has achieved a revenue of 36.92 M USD this year.

How much was the turnover of the company Chembio Diagnostics compared to the previous year?

The revenue of Chembio Diagnostics has increased by -4.98% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Chembio Diagnostics?

The revenue of Chembio Diagnostics is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Chembio Diagnostics measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Chembio Diagnostics so important for investors?

The revenue of Chembio Diagnostics is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Chembio Diagnostics pay?

Over the past 12 months, Chembio Diagnostics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Chembio Diagnostics is expected to pay a dividend of 0 USD.

What is the dividend yield of Chembio Diagnostics?

The current dividend yield of Chembio Diagnostics is .

When does Chembio Diagnostics pay dividends?

Chembio Diagnostics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Chembio Diagnostics?

Chembio Diagnostics paid dividends every year for the past 0 years.

What is the dividend of Chembio Diagnostics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Chembio Diagnostics located?

Chembio Diagnostics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Chembio Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chembio Diagnostics from 9/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/11/2024.

When did Chembio Diagnostics pay the last dividend?

The last dividend was paid out on 9/11/2024.

What was the dividend of Chembio Diagnostics in the year 2023?

In the year 2023, Chembio Diagnostics distributed 0 USD as dividends.

In which currency does Chembio Diagnostics pay out the dividend?

The dividends of Chembio Diagnostics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Chembio Diagnostics

Our stock analysis for Chembio Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chembio Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.